Serial serum AFP heterogeneity changes in patients with hepatocellular carcinoma during chemotherapy
- 1 June 1986
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 17 (2), 182-184
- https://doi.org/10.1007/bf00306751
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Affinity chromatography used in distinguishing alpha-fetoprotein in serum from patients with tumors of hepatic parenchyma and of germ cells.Clinical Chemistry, 1984
- Serum alpha fetoprotein heterogeneity as a means of differentiating between primary hepatocellular carcinoma and hepatic secondariesClinica Chimica Acta; International Journal of Clinical Chemistry, 1984
- ETOPOSIDE: A NEW ANTI-CANCER AGENTThe Lancet, 1981
- A potent antitumour quinazoline inhibitor of thymidylate synthetase: Synthesis, biological properties and therapeutic results in miceEuropean Journal of Cancer (1965), 1981
- Alpha-fetoproteins produced by the yolk sac and the liver are glycosylated differentlyBiochemical and Biophysical Research Communications, 1978
- Developmental changes in carbohydrate moiety of human alpha-fetoproteinInternational Journal of Cancer, 1978
- Glycopeptides derived from individual membrane glycoproteins from control and Rous sarcoma virus-transformed hamster fibroblasts.Journal of Biological Chemistry, 1978
- An abnormal membrane glycoprotein associated with malignancy in a wide range of different tumoursProceedings of the Royal Society of London. B. Biological Sciences, 1978
- α1-Fetoprotein: Separation of two molecular variants by affinity chromatography with concanavalin A-agaroseBiochimica et Biophysica Acta (BBA) - Protein Structure, 1973
- Synthesis of -fetoprotein by liver, yolk sac, and gastrointestinal tract of the human conceptus.1972